From Yahoo Finance: 2025-05-13 15:48:00

Billionaire Ken Griffin’s 10 Midcap Stock Picks with Huge Upside Potential including Neurocrine Biosciences, Inc. (NBIX). Ken Griffin, founder of Citadel, manages $65 billion in assets and is known for successful stock moves. By analyzing his 13F holdings, we ranked midcap stocks based on analyst targets for potential growth.

Neurocrine Biosciences, Inc. (NBIX) has a stock upside potential of 45.88% with Citadel Investment Group holding a stake of $346,451,879. The company develops pharmaceuticals for various disorders and recently received an upgrade from RBC Capital Markets. Despite short-term fluctuations, analysts believe NBIX is a reliable biotech investment with solid long-term prospects.

Neurocrine Biosciences, Inc. (NBIX) reaffirmed its 2025 guidance after beating estimates in the latest quarter. Sales projections for INGREZZA remain strong, demonstrating continuous growth. The company anticipates revenue growth for CRENESSITY despite competition. Ongoing trials for new products show commitment to advancing the pipeline, positioning NBIX as a potential investment.

NBIX ranks 4th on Ken Griffin’s list of midcap stock picks with upside potential. While NBIX shows promise, other AI stocks may offer higher returns in a shorter time frame. An AI stock with significant gains is highlighted for investors seeking alternative opportunities. Explore AI stock options for potential growth beyond traditional pharmaceutical investments.



Read more at Yahoo Finance: Among Billionaire Ken Griffin’s Midcap Stock Picks with Huge Upside Potential